international travel with semaglutide How to Keep Cold When Traveling: Expert Storage Guide Travel with Semaglutide Safely |

Wegovy is the newest among the three semaglutide drugs, approved by the FDA in June 2021 for the treatment of obesity in adults with a body mass index (BMI) of 30 or higher or with a BMI of 27 or higher and at least one weight-related health condition

Managing Side Effects and Injection Site Reactions Local injection site reactions are generally mild and transient with Wegovy thigh injections

If you dont qualify for Ozempic, your provider should explain why and discuss alternative treatments that may be appropriate

Mia S, Sonkar R, Williams L et al (2021) Impact of obesity on day-night differences in cardiac metabolism

And now, Ozempics maker, Novo Nordisk, said it intends to study the phenomenon